{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:23:05Z","timestamp":1791012185098,"version":"4.1.0"},"publisher-location":"Boston, MA","reference-count":42,"publisher":"Springer US","isbn-type":[{"value":"9781461441175","type":"print"},{"value":"9781461441182","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T00:00:00Z","timestamp":1344556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-1-4614-4118-2_5","type":"book-chapter","created":{"date-parts":[[2012,9,18]],"date-time":"2012-09-18T21:26:08Z","timestamp":1348003568000},"page":"83-96","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["DAF as a Therapeutic Target for Steroid Hormones: Implications for Host\u2013Pathogen Interactions"],"prefix":"10.1007","author":[{"given":"Bogdan","family":"Nowicki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Nowicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,10]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"38105","DOI":"10.1074\/jbc.R300028200","volume":"278","author":"S Akira","year":"2003","unstructured":"Akira S (2003) Toll-like receptor signaling. J Biol Chem 278:38105\u201338108","journal-title":"J Biol Chem"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/science.1084550","volume":"301","author":"GG Anderson","year":"2003","unstructured":"Anderson GG, Palermo JJ, Schillin JD, Roth R, Heuser J, Hultgren SJ (2003) Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301:105\u2013107","journal-title":"Science"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2567.1997.00358.x","volume":"90","author":"A Andoh","year":"1997","unstructured":"Andoh A, Fujiyama Y, Sumiyoshi K, Sakumoto H, Okabe H, Bamba T (1997) Tumour necrosis factor-alpha up-regulates decay-accelerating factor gene expression in human intestinal epithelial cells. Immunology 90:358\u2013363","journal-title":"Immunology"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.1073\/pnas.91.13.6245","volume":"91","author":"JM Bergelson","year":"1994","unstructured":"Bergelson JM, Chan M, Solomon KR, St John NF, Lin H, Finberg RW (1994) Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc Natl Acad Sci USA 91:6245\u20136249","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR5","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1128\/JVI.69.3.1903-1906.1995","volume":"69","author":"JM Bergelson","year":"1995","unstructured":"Bergelson JM, Mohanty JG, Crowell RL, St John NF, Lublin DM, Finberg RW (1995) Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol 69:1903\u20131906","journal-title":"J Virol"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1086\/511275","volume":"195","author":"E Curran","year":"2007","unstructured":"Curran E, Tassell AH, Judy BM, Nowicki B, Montgomery-Rice V, Estes DM, Nowicki S (2007) Estrogen increases menopausal host susceptibility to experimental ascending urinary tract infection. J Infect Dis 195:680\u2013683","journal-title":"J Infect Dis"},{"key":"5_CR7","doi-asserted-by":"crossref","first-page":"R1356","DOI":"10.1152\/ajpregu.2001.280.5.R1356","volume":"280","author":"L Fang","year":"2001","unstructured":"Fang L, Nowicki B, Yallampalli C (2001) Differential expression of uterine nitric oxide system in pregnant and nonpregnant rats with intrauterine bacterial infection. Am J Physiol Regul Integr Comp Physiol 280:R1356\u2013R1363","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1128\/IAI.72.5.2907-2914.2004","volume":"72","author":"L Fang","year":"2004","unstructured":"Fang L, Nowicki BJ, Urvil P, Goluszko P, Nowicki S, Young SL, Yallampalli C (2004) Epithelial invasion by Escherichia coli bearing Dr fimbriae is controlled by nitric oxide-regulated expression of CD55. Infect Immun 72:2907\u20132914","journal-title":"Infect Immun"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI119329","volume":"99","author":"P Goluszko","year":"1997","unstructured":"Goluszko P, Moseley S, Truong LD, Kaul A, Nowicki S, Nowicki B (1997) Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H- bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis. J Clin Invest 99:1\u201311","journal-title":"J Clin Invest"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1086\/320196","volume":"183","author":"A Hart","year":"2001","unstructured":"Hart A, Nowicki BJ, Reisner B, Pawelczyk E, Goluszko P, Urvil P, Anderson G, Nowicki S (2001) Ampicillin-resistant Escherichia coli in gestational pyelonephritis: increased occurrence and association with the colonization factor Dr adhesin. J Infect Dis 183:1526\u20131529","journal-title":"J Infect Dis"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/0019-2791(69)90296-1","volume":"6","author":"EM Hoffmann","year":"1969","unstructured":"Hoffmann EM (1969) Inhibition of complement by a substance isolated from human erythrocytes. I. Extraction from human erythrocyte stroma. Immunochemistry 6:391\u2013403","journal-title":"Immunochemistry"},{"key":"5_CR12","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1074\/jbc.M407403200","volume":"280","author":"VR Holla","year":"2005","unstructured":"Holla VR, Wang D, Brown JR, Mann JR, Katkuri S, DuBois RN (2005) Prostaglandin E2 regulates the complement inhibitor CD55\/decay accelerating factor in colorectal cancer. J Biol Chem 280:476\u2013483","journal-title":"J Biol Chem"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1002\/eji.1830220635","volume":"22","author":"CH Holmes","year":"1992","unstructured":"Holmes CH, Simpson KL, Okada H, Okada N, Wainwright SD, Purcell DF, Houlihan JM (1992) Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55). Eur J Immunol 22: 1579\u20131585","journal-title":"Eur J Immunol"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1600-0897.1994.tb01114.x","volume":"32","author":"AK Kaul","year":"1994","unstructured":"Kaul AK, Nowicki BJ, Martens MG, Goluszko P, Hart AR, Nagamani M, Kumar D, Pham T, Nowicki S (1994) Decay accelerating factor (DAF) is expressed in the human endometrium and may serve as the natural ligand for Dr pili of Escherichia coli. Am J Reprod Immunol 32:194\u2013199","journal-title":"Am J Reprod Immunol"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1600-0897.1995.tb00947.x","volume":"34","author":"A Kaul","year":"1995","unstructured":"Kaul A, Nagamani M, Nowicki B (1995) Decreased expression of endometrial decay accelerating factor (DAF), a complement regulatory protein, in patients with luteal phase defect. Am J Reprod Immunol 34:236\u2013240","journal-title":"Am J Reprod Immunol"},{"key":"5_CR16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1128\/IAI.64.2.611-615.1996","volume":"64","author":"A Kaul","year":"1996","unstructured":"Kaul A, Goluszko PG, Hart A, Martens M, Pham T, Nowicki S, Nowicki B (1996) Rapid cycle changes in density and accessibility of endometrial ligands for Escherichia coli Dr fimbriae. Infect Immun 64:611\u2013615","journal-title":"Infect Immun"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1096\/fj.04-3251com","volume":"19","author":"NA Louis","year":"2005","unstructured":"Louis NA, Kong T, Hamilton KE, Colgan SP (2005a) HIF-dependent induction of apical CD55 coordinates epithelial clearance of neutrophils. FASEB J 19:950\u2013959","journal-title":"FASEB J"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1096\/fj.04-3251com","volume":"19","author":"NA Louis","year":"2005","unstructured":"Louis NA, Hamilton KE, Kong T, Colgan SP (2005b) HIF-dependent induction of apical CD55 coordinates epithelial clearance of neutrophils. FASEB J 19:950\u2013959","journal-title":"FASEB J"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"41611","DOI":"10.1074\/jbc.M407981200","volume":"279","author":"JC Mason","year":"2004","unstructured":"Mason JC, Steinberg R, Lidington EA, Kinderlerer AR, Ohba M, Haskard DO (2004) Decay-accelerating factor induction on vascular endothelium by vascular endothelial growth factor (VEGF) is mediated via a VEGF receptor-2 (VEGF-R2)- and protein kinase C-alpha\/epsilon (PKCalpha\/epsilon)-dependent cytoprotective signaling pathway and is inhibited by cyclosporin A. J Biol Chem 279:41611\u201341618","journal-title":"J Biol Chem"},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1046\/j.1537-2995.1996.36496226154.x","volume":"36","author":"JM Moulds","year":"1996","unstructured":"Moulds JM, Nowicki S, Nowicki BJ, Moulds JJ (1996) Human blood groups: incidental receptors for viruses and bacteria. Transfusion 36:362\u2013374","journal-title":"Transfusion"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"5066","DOI":"10.1073\/pnas.80.16.5066","volume":"80","author":"A Nicholson-Weller","year":"1983","unstructured":"Nicholson-Weller A, March JP, Rosenfeld SI, Austen KF (1983) Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor. Proc Natl Acad Sci USA 80:5066\u20135070","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11908-002-0041-z","volume":"4","author":"B Nowicki","year":"2002","unstructured":"Nowicki B (2002) Urinary tract infection in pregnant women: old dogmas and current concepts. Curr Infect Dis Rep 4:529\u2013535","journal-title":"Curr Infect Dis Rep"},{"key":"5_CR23","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1056\/NEJM198811103191916","volume":"319","author":"B Nowicki","year":"1988","unstructured":"Nowicki B, Hull R, Moulds J (1988a) Use of the Dr hemagglutinin of uropathogenic Escherichia coli to differentiate normal from abnormal red cells in paroxysmal nocturnal hemoglobinuria. N Eng J Med 319:1289\u20131290","journal-title":"N Eng J Med"},{"key":"5_CR24","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1128\/IAI.56.5.1057-1060.1988","volume":"56","author":"B Nowicki","year":"1988","unstructured":"Nowicki B, Moulds J, Hull R, Hull S (1988b) A hemagglutinin of uropathogenic E. coli recognized the Dr blood group antigen. Infect Immun 56:1057\u20131060","journal-title":"Infect Immun"},{"key":"5_CR25","first-page":"1","volume":"133","author":"B Nowicki","year":"1988","unstructured":"Nowicki B, Truong L, Moulds J, Hull R (1988c) Presence of the Dr receptor in normal human tissues and its possible role in pathogenesis of ascending urinary tract infection. Am J Pathol 133:1\u20134","journal-title":"Am J Pathol"},{"key":"5_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1600-0897.1997.tb00521.x","volume":"38","author":"B Nowicki","year":"1997","unstructured":"Nowicki B, Fang L, Singhal S, Nowicki S, Yallampalli C (1997) Lethal outcome of uterine infection in pregnant but not in nonpregnant rats and increased death rate with inhibition of nitric oxide. Am J Reprod Immunol 38:309\u2013312","journal-title":"Am J Reprod Immunol"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.8755-8920.2001.460205.x","volume":"46","author":"S Nowicki","year":"2001","unstructured":"Nowicki S, Nowicki B, Pham T, Hasan R, Nagamani M (2001) Expression of decay accelerating factor (DAF) in endometrial adenocarcinoma is inversely related to the stage of tumor. Am J Reprod Immunol 46:144\u2013148","journal-title":"Am J Reprod Immunol"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1600-0897.2009.00702.x","volume":"61","author":"S Nowicki","year":"2009","unstructured":"Nowicki S, Izban M, Pawelczyk E, Agboto V, Pratap S, Olson G, Nowicki B (2009) Preterm labor: CD55 in maternal blood leukocytes. Am J Rep Immunol 61:360\u2013367","journal-title":"Am J Rep Immunol"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1471-0528.2010.02706.x","volume":"218","author":"B Nowicki","year":"2011","unstructured":"Nowicki B, Sledzinska A, Samet A, Nowicki S (2011a) Pathogenesis of gestational UTI: urinary obstruction vs. immune adaptation and microbial virulence. BJOG 218:109\u2013112","journal-title":"BJOG"},{"key":"5_CR30","unstructured":"Nowicki S, Rana T, Singh R, Nowicki B (2011) Dexamethasone treatment downregulates DAF and decrease intracellular survival of Dr \u2009+ \u2009E. coli in HeLa cells. In: Proceedings of the 5th international conference on complement therapeutics, abstract 18, Rhodes, 22\u201327 June 2011"},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"13317","DOI":"10.1074\/jbc.M601805200","volume":"281","author":"DP O\u2019Brien","year":"2006","unstructured":"O\u2019Brien DP, Israel DA, Krishna U, Romero-Gallo J, Nedrud J, Medof ME, Lin F, Redline R, Lublin DM, Nowicki BJ, Franco AT, Ogden S, Williams AD, Polk DB, Peek RM Jr (2006) The role of decay-accelerating factor as a receptor for Helicobacter pylori and a mediator of gastric inflammation. J Biol Chem 281:13317\u201313323","journal-title":"J Biol Chem"},{"key":"5_CR32","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1532-5415.1992.tb01855.x","volume":"40","author":"JD Orlander","year":"1992","unstructured":"Orlander JD, Jick SS, Dean AD, Jick H (1992) Urinary tract infections and estrogen use in older women. J Am Geriatr Soc 40:817\u2013820","journal-title":"J Am Geriatr Soc"},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1055\/s-0031-1274510","volume":"28","author":"LD Pacheco","year":"2011","unstructured":"Pacheco LD, Hankins GD, Costantine MM, Anderson GD, Pawelczyk E, Nowicki S, Nowicki BJ (2011) The role of human decay-accelerating factor in the pathogenesis of preterm labor. Am J Perinatol 28:565\u2013570","journal-title":"Am J Perinatol"},{"key":"5_CR34","doi-asserted-by":"publisher","first-page":"5430","DOI":"10.1073\/pnas.80.17.5430","volume":"80","author":"MK Pangburn","year":"1983","unstructured":"Pangburn MK, Schreiber RD, Muller-Eberhard HJ (1983) Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci USA 80:5430\u20135434","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR35","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1046\/j.8755-8920.2003.00142.x","volume":"51","author":"D Sartini","year":"2004","unstructured":"Sartini D, Moussawi M, Sallam R, Bernstein I, Huber S (2004) Correlation between serum estradiol in the follicular phase of the ovarian cycle and decay acceleration factor (DAF) expression on red blood cells and coxsackievirus B-3 induced hemagglutination in young cycling women. Am J Reprod Immunol 51:180\u2013187","journal-title":"Am J Reprod Immunol"},{"key":"5_CR36","doi-asserted-by":"publisher","first-page":"5899","DOI":"10.1073\/pnas.0510996103","volume":"103","author":"J Schreiber","year":"2006","unstructured":"Schreiber J, Jenner RG, Murray HL, Gerber GK, Gifford DK, Young RA (2006) Coordinated binding of NF-kB family members in the response of human cells to lipopolysaccharide. Proc Natl Acad Sci USA 103:5899\u20135904","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR37","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1128\/IAI.68.3.1391-1399.2000","volume":"68","author":"R Selvarangan","year":"2000","unstructured":"Selvarangan R, Goluszko P, Popov V, Singhal J, Pham T, Lublin DM, Nowicki S, Nowicki B (2000) Role of decay-accelerating factor domains and anchorage in internalization of Dr. fimbriated Escherichia coli. Infect Immun 68:1391\u20131399","journal-title":"Infect Immun"},{"key":"5_CR38","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1471-0528.2010.02732.x","volume":"18","author":"A \u015aledzi\u0144ska","year":"2011","unstructured":"\u015aledzi\u0144ska A, Mielech A, Krawczyk B, Samet A, Nowicki B, Nowicki S, Jankowski Z, Kur J (2011) Fatal sepsis in a pregnant woman with chronic pyelonephritis caused by Escherichia coli bearing Dr and P adhesins: diagnosis based on postmortem strain genotyping. BJOG 18:266\u2013269","journal-title":"BJOG"},{"key":"5_CR39","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.4049\/jimmunol.157.9.4166","volume":"157","author":"WC Song","year":"1996","unstructured":"Song WC, Deng C, Raszmann K, Moore R, Newbold R, McLachlan JA, Negishi M (1996) Mouse decay-accelerating factor: selective and tissue-specific induction by estrogen of the gene encoding the glycosylphosphatidylinositol-anchored form. J Immunol 157:4166\u20134172","journal-title":"J Immunol"},{"key":"5_CR40","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1046\/j.1365-2249.2000.01305.x","volume":"121","author":"OB Spiller","year":"2000","unstructured":"Spiller OB, Criado-Garcia O, Rodriguez DC, Morgan BP (2000) Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack. Clin Exp Immunol 121:234\u2013241","journal-title":"Clin Exp Immunol"},{"key":"5_CR41","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0002-9378(94)70405-8","volume":"170","author":"C Yallampalli","year":"1994","unstructured":"Yallampalli C, Izumi H, Byam-Smith M, Garfield RE (1994) An l-arginine-nitric oxide-cyclic guanosine monophosphate system exists in the uterus and inhibits contractility during pregnancy. Am J Obstet Gynecol 170:175\u2013185","journal-title":"Am J Obstet Gynecol"},{"key":"5_CR42","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1210\/jcem.87.3.8350","volume":"87","author":"SL Young","year":"2002","unstructured":"Young SL, Lessey BA, Fritz MA, Meyer WR, Murray MJ, Speckman PL, Nowicki BJ (2002) In vivo and in vitro evidence suggests that HB-EGF regulates endometrial expression of human decay-accelerating factor. J Clin Endocrinol Metab 87:1368\u20131375","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Advances in Experimental Medicine and Biology","Complement Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4614-4118-2_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T14:43:37Z","timestamp":1714401817000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4614-4118-2_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,10]]},"ISBN":["9781461441175","9781461441182"],"references-count":42,"URL":"https:\/\/doi.org\/10.1007\/978-1-4614-4118-2_5","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,10]]},"assertion":[{"value":"10 August 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}